Advertisement

Candida urinary tract infections in adults

  • Zekaver OdabasiEmail author
  • Ali Mert
Topic Paper
  • 73 Downloads

Abstract

Candiduria is commonly seen in hospitalized patients and most of the patients are asymptomatic, but it may be due to cystitis, pyelonephritis, prostatitis, epididymo-orchitis or disseminated candidiasis. Major risk factors are diabetes mellitus, indwelling urinary catheters, use of broad-spectrum antibiotics, urinary obstruction, and admission to intensive care units. Candida urinary tract infections can be caused by hematogenous spread following candidemia, or retrograde route via the urethra. The presence of Candida species in urine in asymptomatic patients does not warrant antifungal therapy except neutropenic patients, very low-birth-weight infants and patients undergoing urologic procedures. Fluconazole is the treatment of choice for symptomatic infections, it achieves high urinary levels. The other azole antifungals and echinocandins do not reach sufficient urine levels. Amphotericin B deoxycholate is the alternative antifungal agent if fluconazole can not be used because of resistance, allergy or failure.

Keywords

Candiduria Funguria Candida Candida urinary tract infection Fluconazole Amphotericin B 

Notes

Author contributions

ZO literature search and manuscript writing, AM manuscript editing.

References

  1. 1.
    Colodner R, Nuri Y, Chazan B et al (2008) Community-acquired and hospital-acquired candiduria: comparison of prevalence and clinical characteristics. Eur J Clin Microbiol Infect Dis 27:301–305CrossRefPubMedGoogle Scholar
  2. 2.
    Alvarez-Lerma F, Nolla-Salas J, León C et al (2003) Candiduria in critically ill patients admitted to intensive care medical units. Intensive Care Med 29:1069–1076CrossRefPubMedGoogle Scholar
  3. 3.
    Bouza E, San Juan R, Muñoz P et al (2001) A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). European Study Group on Nosocomial Infection. Clin Microbiol Infect 7:532–542CrossRefPubMedGoogle Scholar
  4. 4.
    Padawer D, Pastukh N, Nitzan O et al (2015) Catheter-associated candiduria: risk factors, medical interventions, and antifungal susceptibility. Am J Infect Control 43:e19–e22CrossRefPubMedGoogle Scholar
  5. 5.
    Aubron C, Suzuki S, Glassford NJ et al (2015) The epidemiology of bacteriuria and candiduria in critically ill patients. Epidemiol Infect 143:653–662CrossRefPubMedGoogle Scholar
  6. 6.
    Delgado J, Calvo N, Gomis A et al (2010) Candiduria in renal transplant recipients: incidence, clinical repercussion, and treatment indication. Transplant Proc 42:2944–2946CrossRefPubMedGoogle Scholar
  7. 7.
    Denis B, Chopin D, Piron P et al (2018) Candiduria in kidney transplant recipients: is antifungal therapy useful? Mycoses 61:298–304CrossRefPubMedGoogle Scholar
  8. 8.
    Goetz LL, Howard M, Cipher D et al (2010) Occurrence of candiduria in a population of chronically catheterized patients with spinal cord injury. Spinal Cord 48:51–54CrossRefPubMedGoogle Scholar
  9. 9.
    Esmailzadeh A, Zarrinfar H, Fata A et al (2018) High prevalence of candiduria due to non-albicans Candida species among diabetic patients: a matter of concern? J Clin Lab Anal 32:e22343CrossRefPubMedGoogle Scholar
  10. 10.
    Kauffman CA, Vazquez JA, Sobel JD et al (2000) Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 30:14–18CrossRefPubMedGoogle Scholar
  11. 11.
    Bougnoux ME, Kac G, Aegerter P et al (2008) Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome. Intensive Care Med 34:292–299CrossRefPubMedGoogle Scholar
  12. 12.
    Georgiadou SP, Tarrand J, Sipsas NV et al (2013) Candiduria in haematologic malignancy patients without a urinary catheter: nothing more than a frailty marker? Mycoses 56:311–314CrossRefPubMedGoogle Scholar
  13. 13.
    Drogari-Apiranthitou M, Anyfantis I, Galani I et al (2017) Association between candiduria and candidemia: a clinical and molecular analysis of cases. Mycopathologia 182:1045–1052CrossRefPubMedGoogle Scholar
  14. 14.
    Binelli CA, Moretti ML, Assis RS et al (2006) Investigation of the possible association between nosocomial candiduria and candidaemia. Clin Microbiol Infect 12:538–543CrossRefPubMedGoogle Scholar
  15. 15.
    Safdar N, Slattery WR, Knasinski V et al (2005) Predictors and outcomes of candiduria in renal transplant recipients. Clin Infect Dis 40:1413–1421CrossRefPubMedGoogle Scholar
  16. 16.
    Blumberg HM, Jarvis WR, Soucie JM et al (2001) Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 33:177–186CrossRefPubMedGoogle Scholar
  17. 17.
    Simpson C, Blitz S, Shafran SD (2004) The effect of current management on morbidity and mortality in hospitalised adults with funguria. J Infect 49:248–252CrossRefPubMedGoogle Scholar
  18. 18.
    Wang K, Hsueh K, Kronen R et al (2019) Creation and assessment of a clinical predictive model for candidaemia in patients with candiduria. Mycoses 62:554–561CrossRefPubMedGoogle Scholar
  19. 19.
    Alfouzan WA, Dhar R (2017) Candiduria: evidence-based approach to management, are we there yet? J Mycol Med 27:293–302CrossRefPubMedGoogle Scholar
  20. 20.
    Kauffman CA (2014) Diagnosis and management of fungal urinary tract infection. Infect Dis Clin North Am 28:61–74CrossRefPubMedGoogle Scholar
  21. 21.
    Pappas PG, Kauffman CA, Andes DR et al (2016) Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62:e1–50CrossRefPubMedGoogle Scholar
  22. 22.
    Spivak ES, Hanson KE (2018) Candida auris: an emerging fungal pathogen. J Clin Microbiol.  https://doi.org/10.1128/JCM.01588-17 CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Sobel JD, Fisher JF, Kauffman CA et al (2011) Candida urinary tract infections—epidemiology. Clin Infect Dis 52(Suppl 6):S433–S436CrossRefPubMedGoogle Scholar
  24. 24.
    Fisher JF, Kavanagh K, Sobel JD et al (2011) Candida urinary tract infection: pathogenesis. Clin Infect Dis 52(Suppl 6):S437–S451CrossRefPubMedGoogle Scholar
  25. 25.
    Lewis SS, Knelson LP, Moehring RW et al (2013) Comparison of non-intensive care unit (ICU) versus ICU rates of catheter-associated urinary tract infection in community hospitals. Infect Control Hosp Epidemiol 34:744–747CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Thomas L, Tracy CR (2015) Treatment of fungal urinary tract infection. Urol Clin North Am 42:473–483CrossRefPubMedGoogle Scholar
  27. 27.
    Sobel JD, Vazquez JA (1999) Fungal infections of the urinary tract. World J Urol 17:410–414CrossRefPubMedGoogle Scholar
  28. 28.
    Kontoyiannis DP, Lionakis MS, Lewis RE et al (2005) Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 191:1350–1360CrossRefPubMedGoogle Scholar
  29. 29.
    Pemán J, Ruiz-Gaitán A (2018) Candidemia from urinary tract source: the challenge of candiduria. Hosp Pract 46:243–245CrossRefGoogle Scholar
  30. 30.
    Gaisne R, Jeddi F, Morio F et al (2018) Candida utilis fungaemia following endoscopic intervention on ureteral stent in a kidney transplant recipient: case report and a review of the literature. Mycoses 61:594–599CrossRefPubMedGoogle Scholar
  31. 31.
    Gross M, Winkler H, Pitlik S et al (1998) Unexpected candidemia complicating ureteroscopy and urinary stenting. Eur J Clin Microbiol Infect Dis 17:583–586CrossRefPubMedGoogle Scholar
  32. 32.
    Ang BS, Telenti A, King B et al (1993) Candidemia from a urinary tract source: microbiological aspects and clinical significance. Clin Infect Dis 17:662–666CrossRefPubMedGoogle Scholar
  33. 33.
    Beck SM, Finley DS, Deane LA (2008) Fungal urosepsis after ureteroscopy in cirrhotic patients: a word of caution. Urology 72:291–293CrossRefPubMedGoogle Scholar
  34. 34.
    Fisher J, Mayhall G, Duma R et al (1979) Fungus balls of the urinary tract. South Med J 72(1281–1284):1287Google Scholar
  35. 35.
    Tan WP, Turba UC, Deane LA (2017) Renal fungus ball: a challenging clinical problem. Urologia 84:113–115CrossRefPubMedGoogle Scholar
  36. 36.
    Praz V, Burruni R, Meid F et al (2014) Fungus ball in the urinary tract: a rare entity. Can Urol Assoc J 8:E118–E120CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Kauffman CA, Fisher JF, Sobel JD et al (2011) Candida urinary tract infections–diagnosis. Clin Infect Dis 52(Suppl 6):S452–S456CrossRefPubMedGoogle Scholar
  38. 38.
    Jenkin GA, Choo M, Hosking P et al (1998) Candidal epididymo-orchitis: case report and review. Clin Infect Dis 26:942–945CrossRefPubMedGoogle Scholar
  39. 39.
    Wise GJ, Shteynshlyuger A (2006) How to diagnose and treat fungal infections in chronic prostatitis. Curr Urol Rep 7:320–328CrossRefPubMedGoogle Scholar
  40. 40.
    Sobel JD, Kauffman CA, McKinsey D et al (2000) Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 30:19–24CrossRefPubMedGoogle Scholar
  41. 41.
    Fisher JF (2011) Candida urinary tract infections—epidemiology, pathogenesis, diagnosis, and treatment: executive summary. Clin Infect Dis 52(Suppl 6):S429–S432CrossRefPubMedGoogle Scholar
  42. 42.
    Magri V, Cariani L, Bonamore R et al (2005) Microscopic and microbiological findings for evaluation of chronic prostatitis. Arch Ital Urol Androl 77:135–138PubMedGoogle Scholar
  43. 43.
    Di Paola G, Mogorovich A, Fiorini G et al (2011) Candida bezoars with urinary tract obstruction in two women without immunocompromising conditions. Sci World J 11:1168–1172CrossRefGoogle Scholar
  44. 44.
    Fisher JF, Sobel JD, Kauffman CA et al (2011) Candida urinary tract infections—treatment. Clin Infect Dis 52(Suppl 6):S457–S466CrossRefPubMedGoogle Scholar
  45. 45.
    Jacobs DM, Dilworth TJ, Beyda ND et al (2018) Overtreatment of asymptomatic candiduria among hospitalized patients: a multi-institutional study. Antimicrob Agents Chemother.  https://doi.org/10.1128/AAC.01464-17 CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Leon C, Ruiz-Santana S, Saavedra P et al (2009) Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 37:1624–1633CrossRefPubMedGoogle Scholar
  47. 47.
    Leon C, Ruiz-Santana S, Saavedra P et al (2006) A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 34:730–737CrossRefPubMedGoogle Scholar
  48. 48.
    Pittet D, Monod M, Suter PM et al (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751–758CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Malani AN, Kauffman CA (2007) Candida urinary tract infections: treatment options. Expert Rev Anti Infect Ther 5:277–284CrossRefPubMedGoogle Scholar
  50. 50.
    Miceli MH, Kauffman CA (2015) Isavuconazole: a new broad-spectrum triazole antifungal agent. Clin Infect Dis 61:1558–1565CrossRefPubMedGoogle Scholar
  51. 51.
    Felton T, Troke PF, Hope WW (2014) Tissue penetration of antifungal agents. Clin Microbiol Rev 27:68–88CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Gabardi S, Martin S, Sura M et al (2016) Micafungin treatment and eradication of candiduria among hospitalized patients. Int Urol Nephrol 48:1881–1885CrossRefPubMedGoogle Scholar
  53. 53.
    Grau S, Luque S, Echeverria-Esnal D et al (2016) Urinary micafungin levels are sufficient to treat urinary tract infections caused by Candida spp. Int J Antimicrob Agents 48:212–214CrossRefPubMedGoogle Scholar
  54. 54.
    Sobel JD, Bradshaw SK, Lipka CJ et al (2007) Caspofungin in the treatment of symptomatic candiduria. Clin Infect Dis 44:e46–e49CrossRefPubMedGoogle Scholar
  55. 55.
    Drew RH, Arthur RR, Perfect JR (2005) Is it time to abandon the use of amphotericin B bladder irrigation? Clin Infect Dis 40:1465–1470CrossRefPubMedGoogle Scholar
  56. 56.
    Tuon FF, Amato VS, Penteado Filho SR (2009) Bladder irrigation with amphotericin B and fungal urinary tract infection–systematic review with meta-analysis. Int J Infect Dis 13:701–706CrossRefPubMedGoogle Scholar
  57. 57.
    Chung BH, Chang SY, Kim SI et al (2001) Successfully treated renal fungal ball with continuous irrigation of fluconazole. J Urol 166:1835–1836CrossRefPubMedGoogle Scholar
  58. 58.
    Sobel JD (2007) Vulvovaginal candidosis. Lancet 369:1961–1971CrossRefPubMedGoogle Scholar
  59. 59.
    Cottreau JM, Barr VO (2016) A review of antiviral and antifungal use and safety during pregnancy. Pharmacotherapy 36:668–678CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Infectious Diseases and Clinical Microbiology, School of MedicineMarmara UniversityPendik/IstanbulTurkey
  2. 2.Department of Infectious Diseases and Clinical MicrobiologyIstanbul Medipol UniversityIstanbulTurkey

Personalised recommendations